Scopus Asset Management’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-60,000
Closed -$1.78M 180
2022
Q2
$1.78M Buy
+60,000
New +$2.02M 0.1% 136
2022
Q1
Sell
-74,400
Closed -$3.2M 251
2021
Q4
$3.56M Buy
+74,400
New +$3.34M 0.08% 227
2021
Q3
Sell
-131,181
Closed -$5.93M 342
2021
Q2
$5.93M Sell
131,181
-70,694
-35% -$3.31M 0.08% 230
2021
Q1
$8.92M Sell
201,875
-64,500
-24% -$2.44M 0.11% 198
2020
Q4
$9.26M Buy
+266,375
New +$7.51M 0.15% 176

Other funds holding ADNT

Scopus Asset Management's ADNT Position: Q3 2022 in Review

Scopus Asset Management sold out of Adient (ADNT) in Q3 2022, closing a stake of 60,000 shares — an estimated $1.78M sold.

Scopus Asset Management first reported a position in ADNT in Q4 2020 and held it in 5 quarters. The position peaked at $9.26M in Q4 2020. 248 funds tracked by Wall St. Rank hold ADNT as of Q3 2022.

  • Scopus Asset Management reported no remaining Adient position as of Q3 2022 after selling out during the quarter.
  • Scopus Asset Management sold 60,000 Adient shares in Q3 2022, an estimated $1.78M.
  • Scopus Asset Management first reported a position in Adient in Q4 2020 and held it in 5 quarters.
  • Scopus Asset Management's Adient position peaked at $9.26M in Q4 2020.
  • 248 funds tracked by Wall St. Rank held Adient as of Q3 2022.

Based on Scopus Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.